PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
The public activities coordination tool (PACT) provides an overview of the substance-specific activities that authorities are working on under REACH and the CLP Regulation. These activities are being carried out in line with ECHA’s Integrated Regulatory Strategy.
PACT provides up-to-date information on the activities planned, ongoing or completed by ECHA and/or MSCAs for a given substance in the following areas:
- Data generation and assessment – dossier evaluation, substance evaluation, informal hazard assessment (PBT/vPvB/ED).
- Assessment of regulatory needs (ARN).
- Regulatory risk management – harmonised classification and labelling (CLH) , SVHC identification, recommendations for inclusion in the Authorisation List, restriction.
A summary of all the substance-specific activities can be found under ‘Details’ for each entry.
Further information
- Understanding PACT
- Integrated Regulatory Strategy
- Substances of potential concern
- Dossier Evaluation status
- Substance evaluation
- Endocrine disruptor assessment
- PBT assessment
- Assessment of regulatory needs list
- Registry of CLH intentions until outcome
- Registry of SVHC intentions until outcome
- Recommendations for inclusion in the Authorisation list
- Registry of restriction intentions until outcome
Filter the list
The List does not contain any Substances.
Data generation and assessment | ARN | Regulatory risk management | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Lead cyanamidate | 244-073-9 | 20837-86-9 | - | - | - | - | - | - | 1 | - | - | Details |
Lead di(acetate) | 206-104-4 | 301-04-2 | - | - | - | - | - | - | 1 | - | - | Details |
Lead diazide | 236-542-1 | 13424-46-9 | - | - | - | - | - | - | 1 | - | - | Details |
Lead dinitrate | 233-245-9 | 10099-74-8 | - | - | - | - | - | - | 1 | - | - | Details |
Lead dipicrate | 229-335-2 | 6477-64-1 | - | - | - | - | - | - | 1 | - | - | Details |
Lead hydrogen arsenate | 232-064-2 | 7784-40-9 | - | - | - | - | - | - | 1 | - | - | Details |
Lead monoxide | 215-267-0 | 1317-36-8 | - | - | - | - | - | - | 1 | 2 | - | Details |
Lead oxide sulfate | 234-853-7 | 12036-76-9 | - | - | - | - | - | - | 1 | 1 | - | Details |
Lead sulfochromate yellow
This substance is identified in the Colour Index by Colour Index Constitution Number, C.I. 77603.
|
215-693-7 | 1344-37-2 | - | - | - | - | - | - | 1 | 1 | - | Details |
Lead titanium trioxide | 235-038-9 | 12060-00-3 | - | - | - | - | - | - | 1 | - | - | Details |
Lead titanium zirconium oxide | 235-727-4 | 12626-81-2 | - | - | - | - | - | - | 1 | - | - | Details |
Lead(II) bis(methanesulfonate)
BLEIMETHANSULFONAT; LEAD (II) METHANESULFONATE; LEAD METHANE SULPHONATE; LEAD SALT FP
|
401-750-5 | 17570-76-2 | - | - | - | - | - | - | 1 | - | - | Details |
Lenacil | 218-499-0 | 2164-08-1 | - | - | - | - | - | 1 | - | - | - | Details |
Leucophor 1111X | 700-932-4 | - | - | - | - | - | 1 | - | - | - | - | Details |
Levamfetamine | 205-850-8 | 156-34-3 | - | - | - | - | 1 | - | - | - | - | Details |
LEVODION | 442-550-8 | - | - | - | - | - | 1 | - | - | - | - | Details |
Linalool; (S,R)-3,7-dimethyl-1,6-octadien-3-ol; dl-linalool Coriandrol; (S)-3,7-dimethyl-1,6-octadien-3-ol; d-linalool Licareol; (R)-3,7-dimethyl-1,6-octadien-3-ol; l-linalool
show/hide
|
- | - | - | - | - | - | - | 1 | - | - | - | Details |
Lithium | 231-102-5 | 7439-93-2 | - | - | - | - | 1 | - | - | - | - | Details |
Lithium 1,1-dimethylpropoxide | 485-110-0 | - | - | - | - | - | 1 | - | - | - | - | Details |
Lithium 2-methylpropan-2-olate | 217-611-5 | 1907-33-1 | - | - | - | - | 1 | - | - | - | - | Details |
Lithium acetate | 208-914-3 | 546-89-4 | - | - | - | - | 1 | - | - | - | - | Details |
Lithium acetate dihydrate | 612-081-5 | 6108-17-4 | - | - | - | - | 1 | - | - | - | - | Details |
Lithium amide | 231-968-4 | 7782-89-0 | - | - | - | - | 1 | - | - | - | - | Details |
Lithium benzoate | 209-042-6 | 553-54-8 | - | - | - | - | 1 | - | - | - | - | Details |
Lithium bromide | 231-439-8 | 7550-35-8 | - | - | - | - | 1 | - | - | - | - | Details |
lithium carbonate; lithium chloride; lithium hydroxide
show/hide
|
- | - | - | - | - | - | - | 1 | - | - | - | Details |
Lithium Citrate Tetrahydrate | 612-032-8 | 6080-58-6 | - | - | - | - | 1 | - | - | - | - | Details |
Lithium diisopropylamide | 223-893-0 | 4111-54-0 | - | - | - | - | 1 | - | - | - | - | Details |
Lithium fluoride | 232-152-0 | 7789-24-4 | - | - | - | - | 1 | - | - | - | - | Details |
Lithium hexafluorophosphate(1-) | 244-334-7 | 21324-40-3 | - | - | - | - | 1 | - | - | - | - | Details |
Lithium hydride | 231-484-3 | 7580-67-8 | - | - | - | - | 1 | - | - | - | - | Details |
Lithium hydroxide, monohydrate | 603-454-3 | 1310-66-3 | - | - | - | - | 1 | - | - | - | - | Details |
Lithium hypochlorite | 237-558-1 | 13840-33-0 | - | - | - | - | 1 | - | - | - | - | Details |
Lithium isopropoxide | 424-140-0 | 2388-10-5 | - | - | - | - | 1 | - | - | - | - | Details |
Lithium methanolate | 212-737-7 | 865-34-9 | - | - | - | - | 1 | - | - | - | - | Details |
Lithium nitrate | 232-218-9 | 7790-69-4 | - | - | - | - | 1 | - | - | - | - | Details |
Lithium perchlorate | 232-237-2 | 7791-03-9 | - | - | - | - | 1 | - | - | - | - | Details |
Lithium salicylate | 209-011-7 | 552-38-5 | - | - | - | - | 1 | - | - | - | - | Details |
Lithium sodium 3-amino-10-{4-(10-amino-6,13-dichloro-4,11-disulfonatobenzo[5,6][1,4]oxazino[2,3-b]phenoxazine-3-ylamino)-6-[methyl(2-sulfonato-ethyl)amino]-1,3,5-triazin-2-ylamino}-6,13-dichlorobenzo[5,6][1,4]oxazino[2,3-b]phenoxazine-4,11-disulfonate
DIRECT BLUE FC 57087
|
418-870-9 | 154212-58-5 | - | - | - | - | - | 1 | - | - | - | Details |
Lithium sulfate monohydrate | 600-157-0 | 10102-25-7 | - | - | - | - | 1 | - | - | - | - | Details |
Lithium sulphate | 233-820-4 | 10377-48-7 | - | - | - | - | 1 | - | - | - | - | Details |
Lithium sulphide, anhydrous | 235-228-1 | 12136-58-2 | - | - | - | - | 1 | - | - | - | - | Details |
Lithium-2-methoxyethoxide | 460-000-5 | 20246-63-3 | - | - | - | - | 1 | - | - | - | - | Details |
Long-chain perfluorocarboxylic acids, their salts and related compounds
Long-chain PFCAs and their salts are a homologous series of substances with the molecular formula of CnF2n+1CO2H (where 8 ≤ n ≤ 20). Related compounds are viewed as any substance that is a precursor and may degrade or transform to long-chain PFCAs, where the perfluorinated alkyl moiety has the formula CnF2n+1 (where 8 ≤ n ≤ 20) and is directly bonded to any chemical moiety other than a fluorine, chlorine or bromine atom
|
- | - | - | - | - | - | - | - | - | - | - | Details |
m-bis(2,3-epoxypropoxy)benzene | 202-987-5 | 101-90-6 | - | - | - | - | 1 | 1 | - | - | - | Details |
m-phenoxybenzyl 3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate | 258-067-9 | 52645-53-1 | - | - | - | - | - | 1 | - | - | - | Details |
Magnesium 2-ethylhexanoate | 239-685-8 | 15602-15-0 | - | - | - | - | 1 | - | - | - | - | Details |
Magnesium acrylate | 227-177-9 | 5698-98-6 | - | - | - | - | 1 | - | - | - | - | Details |
Magnesium bis(2-ethylbutanoate) | 421-140-2 | - | - | - | - | - | 1 | - | - | - | - | Details |
Magnesium divanadium hexaoxide | 237-001-2 | 13573-13-2 | - | - | - | - | 1 | - | - | - | - | Details |
EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.